Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer
Ian McNiece(Clinical Research of South Florida), Elizabeth J. Shpall(Scripps MD Anderson Cancer Center), Andrea Steele(University of Colorado Hospital), John Ryder(Eli Lilly (United States)), Janet McDermitt(University of Colorado Hospital), J F Stoltz(University of Colorado Hospital), Yago Nieto(The University of Texas MD Anderson Cancer Center), Wilbur A. Franklin(University of Colorado Health), James R. Murphy(University of Liverpool), Roy B. Jones(The University of Texas MD Anderson Cancer Center), Scott I. Bearman(University of Washington), Pablo J. Cagnoni(University of Colorado Hospital), Peggy Russell(University of Colorado Hospital), Christopher J. Hogan(University of Minnesota)
Cited by 159
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
|Journal of Allergy and Clinical Immunology|2007|933
The Clinical Significance of Positive Blood Cultures: A Comprehensive Analysis of 500 Episodes of Bacteremia and Fungemia in Adults. I. Laboratory and Epidemiologic Observations
|Clinical Infectious Diseases|1983|754
Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2006|702